Diabetes mellitus during interferon therapy for chronic viral hepatitis.
Mofredj
Ali
A
Service de Réanimation, Centre Hospitalier Laennec, Creil, France.
Howaizi
Mehran
M
Grasset
Denis
D
Licht
Henri
H
Loison
Sylvie
S
Devergie
Bruno
B
Demontis
Renato
R
Cadranel
Jean-François
JF
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000503:physiopathology; D016883:Diabetic Ketoacidosis / Q000139:chemically induced; D005260:Female; D020022:Genetic Predisposition to Disease; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male
D000998:Antiviral Agents; D016898:Interferon-alpha